An ‘Adaptive Treatment Strategy’ for Oral Vancomycin in Patients with the Orphan Disease Primary Sclerosing Cholangitis

By sjmartinez • June 20, 2024

Shah A, Tabibian J, Buness C, Holtmann GJ. An 'Adaptive Treatment Strategy' for Oral Vancomycin in Patients with the Orphan Disease Primary Sclerosing Cholangitis. Dig Dis Sci. 2024 Jun 19. doi: 10.1007/s10620-024-08497-4. Epub ahead of print. PMID: 38896361.

Tags: Adaptive treatment strategy, Digestive Diseases, Olive View DoM, Oral vancomycin, Orphan disease, Primary sclerosing cholangitis, Publications, rare disease, Therapeutic decision-making

The PTPN2 rs1893217 IBD risk allele increases susceptibility to AIEC invasion by a JAK-STAT-CEACAM6 axis

Chatterjee P, Canale V, King SJ, Shawki A, Lei H, Santos AN, Haddad M, Gries C, McGovern DPB, Borneman J, McCole DF. The PTPN2 rs1893217 IBD risk[...]

Distal esophageal acid exposure and poor esophageal clearance correlate with probability of progression in Barrett’s esophagus as determined by the tissue systems pathology test

Eriksson SE, Kolb JM, Nguyen J, Sarici IS, Zheng P, Ayazi S. Distal esophageal acid exposure and poor esophageal clearance correlate with probability of progression[...]

Impact of Short Duration FODMAP Restriction on Breath Gases and Gastrointestinal Symptoms

Pathipati MP, Shortt A, Shortt C, McBride B, O'Rourke L, Burke R, Chey WD, Chang L, Staller K. Impact of Short Duration FODMAP Restriction on[...]